Biomarkers for bipolar disorder: current status and challenges ahead

References

• Grande I, Berk M, Birmaher B, et al. Bipolar disorder. Lancet. 2016 Apr 9;387(10027):1561–1572. PubMed PMID: 26388529.
   PubMed Web of Science ®Google Scholar
• Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden Of Disease Study 2010. Lancet. 2013 Nov 9;382(9904):1575–1586. PubMed PMID: 23993280.
   PubMed Web of Science ®Google Scholar
• Hajda M, Prasko J, Latalova K, et al. Unmet needs of bipolar disorder patients. Neuropsychiatr Dis Treat. 2016;12:1561–1570. PubMed PMID: 27445475; PubMed Central PMCID: PMCPMC4928671.
   PubMed Web of Science ®Google Scholar
• Frey BN, Andreazza AC, Houenou J, et al. Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry. 2013;47(4):321–332.
   PubMed Web of Science ®Google Scholar
• Sagar R, Pattanayak RD. Potential biomarkers for bipolar disorder: where do we stand? Indian J Med Res. 2017 Jan;145(1):7–16. PubMed PMID: 28574009; PubMed Central PMCID: PMCPMC5460576.
   PubMed Web of Science ®Google Scholar
• Teixeira AL, Barbosa IG, Machado-Vieira R, et al. Novel biomarkers for bipolar disorder. Expert Opin Med Diagn. 2013 Mar;7(2):147–159. PubMed PMID: 23530885.
   PubMedGoogle Scholar
• Teixeira AL, Salem H, Frey BN, et al. Update on bipolar disorder biomarker candidates. Expert Rev Mol Diagn. 2016 Nov;16(11):1209–1220. PubMed PMID: 27737600.
   PubMed Web of Science ®Google Scholar
• Harrison PJ, Geddes JR, Tunbridge EM. The emerging neurobiology of bipolar disorder. Trends Neurosci. 2018 Jan;41(1):18–30. PubMed PMID: 29169634; PubMed Central PMCID: PMCPMC5755726.
   PubMed Web of Science ®Google Scholar
• Pregelj P. Gene environment interactions in bipolar disorder. Psychiatr Danub. 2011 Sep;23(Suppl 1):S91–S93. PubMed PMID: 21894111.
   PubMedGoogle Scholar
• Craddock N, Sklar P. Genetics of bipolar disorder. Lancet. 2013 May 11;381(9878):1654–1662. PubMed PMID: 23663951.
   PubMed Web of Science ®Google Scholar
• McMahon FJ, Akula N, Schulze TG, et al. Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat Genet. 2010 Feb;42(2):128–131. PubMed PMID: 20081856; PubMed Central PMCID: PMCPMC2854040.
   PubMed Web of Science ®Google Scholar
• Sigitova E, Fisar Z, Hroudova J, et al. Biological hypotheses and biomarkers of bipolar disorder. Psychiatry Clin Neurosci. 2017 Feb;71(2):77–103. PubMed PMID: 27800654.
   PubMed Web of Science ®Google Scholar
• Muneer A. Bipolar disorder: role of inflammation and the development of disease biomarkers. Psychiatry Investig. 2016 Jan;13(1):18–33. PubMed PMID: 26766943; PubMed Central PMCID: PMCPMC4701682.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Okusaga OO, Quevedo J, et al. The potential association between obesity and bipolar disorder: a meta-analysis. J Affect Disord. 2016 Sep 15;202:120–123. PubMed PMID: 27262632; eng.
   PubMed Web of Science ®Google Scholar
• Angst F, Stassen HH, Clayton PJ, et al. Mortality of patients with mood disorders: follow-up over 34–38 years. J Affect Disord. 2002 Apr;68(2–3):167–181. PubMed PMID: 12063145.
   PubMed Web of Science ®Google Scholar
• Tsai SY, Lee CH, Kuo CJ, et al. A retrospective analysis of risk and protective factors for natural death in bipolar disorder. J Clin Psychiatry. 2005 Dec;66(12):1586–1591. PubMed PMID: 16401162.
   PubMed Web of Science ®Google Scholar
• Williams MD, Shah ND, Wagie AE, et al. Direct costs of bipolar disorder versus other chronic conditions: an employer-based health plan analysis. Psychiatr Serv. 2011 Sep;62(9):1073–1078.
   PubMed Web of Science ®Google Scholar
• Fagiolini A, Frank E, Scott JA, et al. Metabolic syndrome in bipolar disorder: findings from the bipolar disorder center for Pennsylvanians. Bipolar Disord. 2005 Oct;7(5):424–430. PubMed PMID: 16176435.
   PubMed Web of Science ®Google Scholar
• Chang CK, Hayes RD, Perera G, et al. Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PloS one. 2011;6(5):e19590. PubMed PMID: 21611123; PubMed Central PMCID: PMCPMC3097201.
   PubMed Web of Science ®Google Scholar
• Barbosa IG, Machado-Vieira R, Soares JC, et al. The immunology of bipolar disorder. Neuroimmunomodulation. 2014;21(2–3):117–122. PubMed PMID: 24557044; PubMed Central PMCID: PMCPMC4041530.
   PubMed Web of Science ®Google Scholar
• Becking K, Haarman BC, van der Lek RF, et al. Inflammatory monocyte gene expression: trait or state marker in bipolar disorder? Int J Bipolar Disord. 2015 Dec;3(1):20. PubMed PMID: 26381439; PubMed Central PMCID: PMCPMC4574035.
   PubMed Web of Science ®Google Scholar
• Sayana P, Colpo GD, Simoes LR, et al. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients. J Psychiatr Res. 2017 Sep;92:160–182. PubMed PMID: 28458141; eng.
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R. Lithium, stress, and resilience in bipolar disorder: deciphering this key homeostatic synaptic plasticity regulator. J Affect Disord. 2018 Jun;233:92–99. PubMed PMID: 29310970.
   PubMed Web of Science ®Google Scholar
• Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011 Jan;35(3):804–817. PubMed PMID: 20934453.
   PubMed Web of Science ®Google Scholar
• Mwangi B, Wu MJ, Cao B, et al. Individualized prediction and clinical staging of bipolar disorders using neuroanatomical biomarkers. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Mar 1;1(2):186–194. PubMed PMID: 27047994; PubMed Central PMCID: PMCPMC4817111.
   PubMedGoogle Scholar
• Manchia M, Carpiniello B. Personalized psychiatry: promises and pitfalls. Neurosci Lett. 2018 Mar 16;669:1–2. PubMed PMID: 28238707.
   PubMed Web of Science ®Google Scholar
• Alda M, Manchia M. Personalized management of bipolar disorder. Neurosci Lett. 2018 Mar 16;669:3–9. PubMed PMID: 29208408.
   PubMed Web of Science ®Google Scholar
• de Oliveira GS, Cereser KM, Fernandes BS, et al. Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res. 2009 Sep;43(14):1171–1174. PubMed PMID: 19473667.
   PubMed Web of Science ®Google Scholar
• Grande I, Fries GR, Kunz M, et al. The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig. 2010 Dec;7(4):243–250. PubMed PMID: 21253407; PubMed Central PMCID: PMCPMC3022310.
   PubMed Web of Science ®Google Scholar
• Sodersten K, Palsson E, Ishima T, et al. Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts. J Affect Disord. 2014 May;160:1–9. PubMed PMID: 24709015.
   PubMed Web of Science ®Google Scholar
• Fernandes BS, Gama CS, Cereser KM, et al. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res. 2011 Aug;45(8):995–1004. PubMed PMID: 21550050.
   PubMed Web of Science ®Google Scholar
• Munkholm K, Vinberg M, Kessing LV. Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis. Mol Psychiatry. 2016 Feb;21(2):216–228. PubMed PMID: 26194180.
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Dias VV, Kauer-Sant’Anna M, et al. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1366–1371. PubMed PMID: 19666076.
   PubMed Web of Science ®Google Scholar
• de Sousa RT, van de Bilt MT, Diniz BS, et al. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neurosci Lett. 2011 Apr 20;494(1):54–56. PubMed PMID: 21362460.
   PubMed Web of Science ®Google Scholar
• Tramontina JF, Andreazza AC, Kauer-Sant’anna M, et al. Brain-derived neurotrophic factor serum levels before and after treatment for acute mania. Neurosci Lett. 2009 Mar 13;452(2):111–113. PubMed PMID: 19383424.
   PubMed Web of Science ®Google Scholar
• Chan KL, Tong KY, Yip SP. Relationship of serum brain-derived neurotrophic factor (BDNF) and health-related lifestyle in healthy human subjects. Neurosci Lett. 2008 Dec 12;447(2–3):124–128. PubMed PMID: 18852019.
   PubMed Web of Science ®Google Scholar
• Squassina A, Costa M, Congiu D, et al. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients. Pharmacol Res. 2013 Jul;73:1–7. PubMed PMID: 23619527.
   PubMed Web of Science ®Google Scholar
• Kikuchi K, Iga J, Tayoshi S, et al. Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and patients with bipolar disorder. Hum Psychopharmacol. 2011 Jun-Jul;26(4–5):358–363. PubMed PMID: 21721043.
   PubMed Web of Science ®Google Scholar
• Lee BH, Kim YK. Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders. J Affect Disord. 2012 Jan;136(1–2):181–184. PubMed PMID: 21862441.
   PubMed Web of Science ®Google Scholar
• Shibata T, Yamagata H, Uchida S, et al. The alteration of hypoxia inducible factor-1 (HIF-1) and its target genes in mood disorder patients. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:222–229. PubMed PMID: 23333658.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang T, He S, et al. Elevated serum levels of FGF-2, NGF and IGF-1 in patients with manic episode of bipolar disorder. Psychiatry Res. 2014 Aug 15;218(1–2):54–60. PubMed PMID: 24793757.
   PubMed Web of Science ®Google Scholar
• Walz JC, Andreazza AC, Frey BN, et al. Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neurosci Lett. 2007 Mar 19;415(1):87–89. PubMed PMID: 17234344.
   PubMed Web of Science ®Google Scholar
• Fernandes BS, Gama CS, Walz JC, et al. Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes. J Psychiatr Res. 2010 Jul;44(9):561–565. PubMed PMID: 20060128.
   PubMed Web of Science ®Google Scholar
• Loch AA, Zanetti MV, de Sousa RT, et al. Elevated neurotrophin-3 and neurotrophin 4/5 levels in unmedicated bipolar depression and the effects of lithium. Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jan 2;56:243–246. PubMed PMID: 25290636.
   PubMed Web of Science ®Google Scholar
• Tseng PT, Chen YW, Tu KY, et al. State-dependent increase in the levels of neurotrophin-3 and neurotrophin-4/5 in patients with bipolar disorder: a meta-analysis. J Psychiatr Res. 2016 Aug;79:86–92. PubMed PMID: 27214525.
   PubMed Web of Science ®Google Scholar
• Rowland T, Perry BI, Upthegrove R, et al. Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses. Br J Psychiatry. 2018 Sep;213(3):514–525. PubMed PMID: 30113291.
   PubMed Web of Science ®Google Scholar
• Walz JC, Magalhaes PV, Giglio LM, et al. Increased serum neurotrophin-4/5 levels in bipolar disorder. J Psychiatr Res. 2009 Apr;43(7):721–723. PubMed PMID: 19081579.
   PubMed Web of Science ®Google Scholar
• Barbosa IG, Morato IB, Huguet RB, et al. Decreased plasma neurotrophin-4/5 levels in bipolar disorder patients in mania. Rev Bras Psiquiatr. 2014 Oct-Dec;36(4):340–343. PubMed PMID: 25076171.
   PubMed Web of Science ®Google Scholar
• Munkholm K, Brauner JV, Kessing LV, et al. Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res. 2013 Sep;47(9):1119–1133. PubMed PMID: 23768870.
   PubMed Web of Science ®Google Scholar
• Modabbernia A, Taslimi S, Brietzke E, et al. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry. 2013 Jul 1;74(1):15–25. PubMed PMID: 23419545.
   PubMed Web of Science ®Google Scholar
• Barbosa IG, Bauer ME, Machado-Vieira R, et al. Cytokines in bipolar disorder: paving the way for neuroprogression. Neural Plast. 2014;2014:360481. PubMed PMID: 25313338; PubMed Central PMCID: PMCPMC4172873.
   PubMed Web of Science ®Google Scholar
• Stuart MJ, Baune BT. Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies. Neurosci Biobehav Rev. 2014 May;42:93–115. PubMed PMID: 24513303.
   PubMed Web of Science ®Google Scholar
• Kauer-Sant’Anna M, Kapczinski F, Andreazza AC, et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol. 2009 May;12(4):447–458. PubMed PMID: 18771602.
   PubMed Web of Science ®Google Scholar
• Dickerson F, Stallings C, Origoni A, et al. C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophr Res. 2007 Jul;93(1–3):261–265. PubMed PMID: 17490859.
   PubMed Web of Science ®Google Scholar
• Uyanik V, Tuglu C, Gorgulu Y, et al. Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment. Psychiatry Res. 2015 Aug 30;228(3):386–392. PubMed PMID: 26160203.
   PubMed Web of Science ®Google Scholar
• Mazza MG, Lucchi S, Tringali AGM, et al. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jun 8;84(Pt A):229–236. PubMed PMID: 29535038.
   PubMed Web of Science ®Google Scholar
• Scola G, Kim HK, Young LT, et al. A fresh look at complex I in microarray data: clues to understanding disease-specific mitochondrial alterations in bipolar disorder. Biol Psychiatry. 2013 Jan 15;73(2):e4–5. PubMed PMID: 22846438.
   PubMed Web of Science ®Google Scholar
• Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol. 1997 Mar;82(2):291–295. PubMed PMID: 9129943.
   PubMed Web of Science ®Google Scholar
• Brown NC, Andreazza AC, Young LT. An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res. 2014 Aug 15;218(1–2):61–68. PubMed PMID: 24794031.
   PubMed Web of Science ®Google Scholar
• Elmorsy E, Shahda M, Mahmoud El HM, et al. Blood lactate levels as a biomarker of antipsychotic side effects in patients with schizophrenia. J Psychopharmacol. 2016 Jan;30(1):63–68. PubMed PMID: 26577064.
   PubMed Web of Science ®Google Scholar
• Yoshimi N, Futamura T, Kakumoto K, et al. Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder. BBA Clin. 2016 Jun;5:151–158. PubMed PMID: 27114925; PubMed Central PMCID: PMCPMC4832124.
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Dal-Pizzol F, Teixeira AL, et al. A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol Psychiatry. 2010 Aug;15(8):784–786. PubMed PMID: 20351717.
   PubMed Web of Science ®Google Scholar
• Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016 Dec;21(12):1696–1709. PubMed PMID: 26903267; PubMed Central PMCID: PMCPMC6056174.
   PubMed Web of Science ®Google Scholar
• Schroeter ML, Abdul-Khaliq H, Diefenbacher A, et al. S100B is increased in mood disorders and may be reduced by antidepressive treatment. Neuroreport. 2002 Sep 16;13(13):1675–1678. PubMed PMID: 12352625.
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Lara DR, Portela LV, et al. Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study. Eur Neuropsychopharmacol. 2002 Jun;12(3):269–272. PubMed PMID: 12007679.
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Cassini C, Rosa AR, et al. Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res. 2007 Sep;41(6):523–529. PubMed PMID: 16956621.
   PubMed Web of Science ®Google Scholar
• Tsai MC, Huang TL. Decreased S100B serum levels after treatment in bipolar patients in a manic phase. Compr Psychiatry. 2017 Apr;74:27–34. PubMed PMID: 28088747.
   PubMed Web of Science ®Google Scholar
• Wiener CD, Jansen K, Ghisleni G, et al. Reduced serum levels of neuron specific enolase (NSE) in drug-naive subjects with major depression and bipolar disorder. Neurochem Res. 2013 Jul;38(7):1394–1398. PubMed PMID: 23564292.
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Andreazza AC, Viale CI, et al. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett. 2007 Jun 21;421(1):33–36. PubMed PMID: 17548157.
   PubMed Web of Science ®Google Scholar
• Rosso G, Cattaneo A, Zanardini R, et al. Glucose metabolism alterations in patients with bipolar disorder. J Affect Disord. 2015 Sep 15;184:293–298. PubMed PMID: 26120808.
   PubMed Web of Science ®Google Scholar
• Platzer M, Fellendorf FT, Bengesser SA, et al. Adiponectin is decreased in bipolar depression. World J Biol Psychiatry. 2018 Jul 26:1–23. PubMed PMID: 30047831. DOI:10.1080/15622975.2018.1500033.
   Google Scholar
• Ribeiro HC, Klassen A, Pedrini M, et al. A preliminary study of bipolar disorder type I by mass spectrometry-based serum lipidomics. Psychiatry Res. 2017 Dec;258:268–273. PubMed PMID: 28918859.
   PubMed Web of Science ®Google Scholar
• Frye MA, Nassan M, Jenkins GD, et al. Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders. Transl Psychiatry. 2015;5:e689.
   PubMed Web of Science ®Google Scholar
• Comes AL, Papiol S, Mueller T, et al. Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future. Transl Psychiatry. 2018 Aug 16;8(1):160. .
   PubMed Web of Science ®Google Scholar
• Fries GR, Carvalho AF, Quevedo J. The miRNome of bipolar disorder. J Affect Disord. 2018 Jun;233:110–116. PubMed PMID: 28969861.
   PubMed Web of Science ®Google Scholar
• Knorr U, Simonsen AH, Zetterberg H, et al. Biomarkers in cerebrospinal fluid of patients with bipolar disorder versus healthy individuals: a systematic review. Eur Neuropsychopharmacol. 2018 Jul;28(7):783–794. PubMed PMID: 29802040.
   PubMed Web of Science ®Google Scholar
• Palsson E, Sellgren C, Ryden E, et al. Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls. J Neural Transm (Vienna). 2017 Sep;124(9):1135–1143. PubMed PMID: 28656371; PubMed Central PMCID: PMCPMC5565665.
   PubMed Web of Science ®Google Scholar
• Isgren A, Sellgren C, Ekman CJ, et al. Markers of neuroinflammation and neuronal injury in bipolar disorder: relation to prospective clinical outcomes. Brain Behav Immun. 2017 Oct;65:195–201. PubMed PMID: 28483660.
   PubMed Web of Science ®Google Scholar
• Yoshimi N, Futamura T, Bergen SE, et al. Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis. Mol Psychiatry. 2016 Nov;21(11):1504–1510. PubMed PMID: 26782057; PubMed Central PMCID: PMCPMC5078854.
   PubMed Web of Science ®Google Scholar
• Forlenza OV, Aprahamian I, Radanovic M, et al. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer’s disease pathological signature in the cerebrospinal fluid. Bipolar Disord. 2016 Feb;18(1):63–70. PubMed PMID: 26876913.
   PubMed Web of Science ®Google Scholar
• Kieseppa T, Partonen T, Haukka J, et al. High concordance of bipolar I disorder in a nationwide sample of twins. Am J Psychiatry. 2004 Oct;161(10):1814–1821. PubMed PMID: 15465978; eng.
   PubMed Web of Science ®Google Scholar
• McGuffin P, Rijsdijk F, Andrew M, et al. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry. 2003 May;60(5):497–502. PubMed PMID: 12742871; eng.
   PubMed Web of Science ®Google Scholar
• Otte C, Gold SM, Penninx BW, et al. Major depressive disorder. Nat Rev Dis Primers. 2016 Sep 15;2:16065. PubMed PMID: 27629598; eng.
   PubMed Web of Science ®Google Scholar
• Gonzalez S, Camarillo C, Rodriguez M, et al. A genome-wide linkage scan of bipolar disorder in Latino families identifies susceptibility loci at 8q24 and 14q32. Am J Med Genet B Neuropsychiatr Genet. 2014 Sep;165b(6):479–491. PubMed PMID: 25044503; eng.
   PubMedGoogle Scholar
• Neale BM, Sklar P. Genetic analysis of schizophrenia and bipolar disorder reveals polygenicity but also suggests new directions for molecular interrogation. Curr Opin Neurobiol. 2015 Feb;30:131–138. PubMed PMID: 25544106; eng.
   PubMed Web of Science ®Google Scholar
• Welter D, MacArthur J, Morales J, et al. The NHGRI GWAS catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 2014 Jan;42(Database issue):D1001–6. PubMed PMID: 24316577; PubMed Central PMCID: PMCPMC3965119. eng.
   PubMed Web of Science ®Google Scholar
• Ruderfer DM, Fanous AH, Ripke S, et al. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol Psychiatry. 2014 Sep;19(9):1017–1024. PubMed PMID: 24280982; PubMed Central PMCID: PMCPMC4033708. eng.
   PubMed Web of Science ®Google Scholar
• Chen DT, Jiang X, Akula N, et al. Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry. 2013 Feb;18(2):195–205. PubMed PMID: 22182935; eng.
   PubMed Web of Science ®Google Scholar
• Hou L, Bergen SE, Akula N, et al. Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder. Hum Mol Genet. 2016 Aug 1;25(15):3383–3394. PubMed PMID: 27329760; PubMed Central PMCID: PMCPMC5179929. eng.
   PubMed Web of Science ®Google Scholar
• Sleiman P, Wang D, Glessner J, et al. GWAS meta analysis identifies TSNARE1 as a novel schizophrenia/bipolar susceptibility locus. Sci Rep. 2013 Oct 29;3:3075. PubMed PMID: 24166486; PubMed Central PMCID: PMCPMC3810676. eng.
   PubMed Web of Science ®Google Scholar
• Muhleisen TW, Leber M, Schulze TG, et al. Genome-wide association study reveals two new risk loci for bipolar disorder. Nat Commun. 2014 Mar 11;5:3339. PubMed PMID: 24618891; eng.
   PubMed Web of Science ®Google Scholar
• Ikeda M, Takahashi A, Kamatani Y, et al. A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder. Mol Psychiatry. 2018 Mar;23(3):639–647. PubMed PMID: 28115744; PubMed Central PMCID: PMCPMC5822448. eng.
   PubMed Web of Science ®Google Scholar
• Mistry S, Harrison JR, Smith DJ, et al. The use of polygenic risk scores to identify phenotypes associated with genetic risk of bipolar disorder and depression: a systematic review. J Affect Disord. 2018 Jul;234:148–155. PubMed PMID: 29529547; eng.
   PubMed Web of Science ®Google Scholar
• Fullerton JM, Koller DL, Edenberg HJ, et al. Assessment of first and second degree relatives of individuals with bipolar disorder shows increased genetic risk scores in both affected relatives and young at-risk individuals. Am J Med Genet B Neuropsychiatr Genet. 2015 Oct;168(7):617–629. PubMed PMID: 26178159; PubMed Central PMCID: PMCPMC5054905. eng.
   PubMed Web of Science ®Google Scholar
• Dezhina Z, Ranlund S, Kyriakopoulos M, et al. A systematic review of associations between functional MRI activity and polygenic risk for schizophrenia and bipolar disorder. Brain Imaging Behav. 2018 May 10. PubMed PMID: 29748770; eng. DOI:10.1007/s11682-018-9879-z
   PubMedGoogle Scholar
• Pisanu C, Heilbronner U, Squassina A. The role of pharmacogenomics in bipolar disorder: moving towards precision medicine. Mol Diagn Ther. 2018 May 22;22:409–420. PubMed PMID: 29790107; eng.
   PubMed Web of Science ®Google Scholar
• Amare AT, Schubert KO, Hou L, et al. Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder: a genome-wide association study. JAMA psychiatry. 2018 Jan 1;75(1):65–74. PubMed PMID: 29121268; PubMed Central PMCID: PMCPMC5833535. eng.
   PubMed Web of Science ®Google Scholar
• Hou L, Heilbronner U, Degenhardt F, et al. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet. 2016 Mar 12;387(10023):1085–1093. PubMed PMID: 26806518; PubMed Central PMCID: PMCPMC4814312. eng.
   PubMed Web of Science ®Google Scholar
• Walss-Bass C, Fries GR. Are lithium effects dependent on genetic/epigenetic architecture? Neuropsychopharmacology. 2019 Jan;44(1):228. doi: 10.1038/s41386-018-0194-6. PMID: 30194423.
   Google Scholar
• Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013 Apr 20;381(9875):1371–1379. PubMed PMID: 23453885; PubMed Central PMCID: PMCPMC3714010. eng.
   PubMed Web of Science ®Google Scholar
• van Hulzen KJE, Scholz CJ, Franke B, et al. Genetic overlap between attention-deficit/hyperactivity disorder and bipolar disorder: evidence from genome-wide association study meta-analysis. Biol Psychiatry. 2017 Nov 1;82(9):634–641. PubMed PMID: 27890468; eng.
   PubMed Web of Science ®Google Scholar
• Witt SH, Streit F, Jungkunz M, et al. Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Transl Psychiatry. 2017 Jun 20;7(6):e1155. PubMed PMID: 28632202; PubMed Central PMCID: PMCPMC5537640. eng.
   PubMedGoogle Scholar
• Forstner AJ, Hecker J, Hofmann A, et al. Identification of shared risk loci and pathways for bipolar disorder and schizophrenia. PloS one. 2017;12(2):e0171595. PubMed PMID: 28166306; PubMed Central PMCID: PMCPMC5293228. eng.
   PubMed Web of Science ®Google Scholar
• Schulze TG, Akula N, Breuer R, et al. Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder. World J Biol Psychiatry. 2014 Apr;15(3):200–208. PubMed PMID: 22404658; PubMed Central PMCID: PMCPMC3406228. eng.
   PubMed Web of Science ®Google Scholar
• Fries GR, Li Q, McAlpin B, et al. The role of DNA methylation in the pathophysiology and treatment of bipolar disorder. Neurosci Biobehav Rev. 2016 Sep;68:474–488. PubMed PMID: 27328785; PubMed Central PMCID: PMCPMC5003658. eng.
   PubMed Web of Science ®Google Scholar
• Ludwig B, Dwivedi Y. Dissecting bipolar disorder complexity through epigenomic approach. Mol Psychiatry. 2016 Nov;21(11):1490–1498. PubMed PMID: 27480490; PubMed Central PMCID: PMCPMC5071130. eng.
   PubMed Web of Science ®Google Scholar
• Fries GR, Quevedo J, Zeni CP, et al. Integrated transcriptome and methylome analysis in youth at high risk for bipolar disorder: a preliminary analysis. Transl Psychiatry. 2017 Mar 14;7(3):e1059. PubMed PMID: 28291257; PubMed Central PMCID: PMCPMC5416675. eng.
   PubMedGoogle Scholar
• Charney AW, Ruderfer DM, Stahl EA, et al. Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder. Transl Psychiatry. 2017 Jan 10;7(1):e993. PubMed PMID: 28072414; PubMed Central PMCID: PMCPMC5545718.
   PubMedGoogle Scholar
• Goes FS, Hamshere ML, Seifuddin F, et al. Genome-wide association of mood-incongruent psychotic bipolar disorder. Transl Psychiatry. 2012 Oct 23;2:e180. PubMed PMID: 23092984; PubMed Central PMCID: PMCPMC3565814.
   PubMed Web of Science ®Google Scholar
• Greenwood TA, Bipolar Genome Study C, Kelsoe JR. Genome-wide association study of irritable vs. elated mania suggests genetic differences between clinical subtypes of bipolar disorder. PloS one. 2013;8(1):e53804. PubMed PMID: 23326512; PubMed Central PMCID: PMCPMC3542199.
   PubMed Web of Science ®Google Scholar
• Jamain S, Cichon S, Etain B, et al. Common and rare variant analysis in early-onset bipolar disorder vulnerability. PloS one. 2014;9(8):e104326. PubMed PMID: 25111785; PubMed Central PMCID: PMCPMC4128749.
   PubMed Web of Science ®Google Scholar
• Nortje G, Stein DJ, Radua J, et al. Systematic review and voxel-based meta-analysis of diffusion tensor imaging studies in bipolar disorder. J Affect Disord. 2013 Sep 5;150(2):192–200. PubMed PMID: 23810479; eng.
   PubMed Web of Science ®Google Scholar
• Dwyer DB, Falkai P, Koutsouleris N. Machine learning approaches for clinical psychology and psychiatry. Annu Rev Clin Psychol. 2018;14:91–118.
   PubMed Web of Science ®Google Scholar
• Kambeitz J, Kambeitz-Ilankovic L, Leucht S, et al. Detecting neuroimaging biomarkers for schizophrenia: a meta-analysis of multivariate pattern recognition studies. Neuropsychopharmacology. 2015;40(7):1742.
   PubMed Web of Science ®Google Scholar
• Wu M-J, Mwangi B, Bauer IE, et al. Identification and individualized prediction of clinical phenotypes in bipolar disorders using neurocognitive data, neuroimaging scans and machine learning. Neuroimage. 2017;145:254–264.
   PubMed Web of Science ®Google Scholar
• Abé C, Rolstad S, Petrovic P, et al. Bipolar disorder type I and II show distinct relationships between cortical thickness and executive function. Acta Psychiatr Scand. 2018;138:325–335.
   PubMed Web of Science ®Google Scholar
• Bürger C, Redlich R, Grotegerd D, et al. Differential abnormal pattern of anterior cingulate gyrus activation in unipolar and bipolar depression: an fMRI and pattern classification approach. Neuropsychopharmacology. 2017;42(7):1399.
   PubMed Web of Science ®Google Scholar
• Chen L, Wang Y, Niu C, et al. Common and distinct abnormal frontal-limbic system structural and functional patterns in patients with major depression and bipolar disorder. NeuroImage Clin. 2018;20:42–50.
   PubMed Web of Science ®Google Scholar
• Goya‐Maldonado R, Brodmann K, Keil M, et al. Differentiating unipolar and bipolar depression by alterations in large‐scale brain networks. Hum Brain Mapp. 2016;37(2):808–818.
   PubMed Web of Science ®Google Scholar
• Grant K, Hassel S, Bobyn JA, et al. A novel task for examining the neural basis of theory of mind deficits in bipolar disorder. Psychiatry Res Neuroimaging. 2018 Jun 4. pii: S0925-4927(17)30265-2. doi: 10.1016/j.pscychresns.2018.06.001. [Epub ahead of print].
   Google Scholar
• Frey BN, Zunta-Soares GB, Caetano SC, et al. Illness duration and total brain gray matter in bipolar disorder: evidence for neurodegeneration? Eur Neuropsychopharmacol. 2008;18(10):717–722.
   PubMed Web of Science ®Google Scholar
• Moorhead TWJ, McKirdy J, Sussmann JE, et al. Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry. 2007;62(8):894–900.
   PubMed Web of Science ®Google Scholar
• Lisy ME, Jarvis KB, DelBello MP, et al. Progressive neurostructural changes in adolescent and adult patients with bipolar disorder. Bipolar Disord. 2011;13(4):396–405.
   PubMed Web of Science ®Google Scholar
• Konarski JZ, McIntyre RS, Kennedy SH, et al. Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord. 2008;10(1):1–37.
   PubMed Web of Science ®Google Scholar
• Phillips ML, Swartz HA. A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research. Am J Psychiatry. 2014 Aug;171(8):829–843. PubMed PMID: 24626773; PubMed Central PMCID: PMCPMC4119497. eng.
   PubMed Web of Science ®Google Scholar
• De Peri L, Crescini A, Deste G, et al. Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies. Curr Pharm Des. 2012;18(4):486–494.
   PubMed Web of Science ®Google Scholar
• Pfeifer JC, Welge J, Strakowski SM, et al. Meta-analysis of amygdala volumes in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2008;47(11):1289–1298.
   PubMed Web of Science ®Google Scholar
• Foland LC, Altshuler LL, Sugar CA, et al. Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium. Neuroreport. 2008;19(2):221.
   PubMed Web of Science ®Google Scholar
• Bearden CE, Thompson PM, Dutton RA, et al. Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology. 2008;33(6):1229.
   PubMed Web of Science ®Google Scholar
• Koutsouleris N, Meisenzahl EM, Borgwardt S, et al. Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers. Brain. 2015;138(7):2059–2073.
   PubMedGoogle Scholar
• Redlich R, Almeida JR, Grotegerd D, et al. Brain morphometric biomarkers distinguishing unipolar and bipolar depression: a voxel-based morphometry–pattern classification approach. JAMA psychiatry. 2014;71(11):1222–1230.
   PubMed Web of Science ®Google Scholar
• Nunes A, Schnack HG, Ching CRK, et al. Using structural MRI to identify bipolar disorders - 13 site machine learning study in 3020 individuals from the ENIGMA Bipolar Disorders Working Group. Mol Psychiatry. 2018 Aug 31. PubMed PMID: 30171211. DOI:10.1038/s41380-018-0228-9
   PubMedGoogle Scholar
• Hanford LC, Nazarov A, Hall GB, et al. Cortical thickness in bipolar disorder: a systematic review. Bipolar Disord. 2016;18(1):4–18.
   PubMed Web of Science ®Google Scholar
• Elvsåshagen T, Westlye LT, Bøen E, et al. Bipolar II disorder is associated with thinning of prefrontal and temporal cortices involved in affect regulation. Bipolar Disord. 2013;15(8):855–864.
   PubMed Web of Science ®Google Scholar
• Foland-Ross LC, Thompson PM, Sugar CA, et al. Investigation of cortical thickness abnormalities in lithium-free adults with bipolar I disorder using cortical pattern matching. Am J Psychiatry. 2011;168(5):530–539.
   PubMed Web of Science ®Google Scholar
• Fornito A, Malhi GS, Lagopoulos J, et al. Anatomical abnormalities of the anterior cingulate and paracingulate cortex in patients with bipolar I disorder. Psychiatry Res Neuroim. 2008;162(2):123–132.
   PubMed Web of Science ®Google Scholar
• Qiu A, Vaillant M, Barta P, et al. Region‐of‐interest‐based analysis with application of cortical thickness variation of left planum temporale in schizophrenia and psychotic bipolar disorder. Hum Brain Mapp. 2008;29(8):973–985.
   PubMed Web of Science ®Google Scholar
• Hegarty CE, Foland‐Ross LC, Narr KL, et al. ADHD comorbidity can matter when assessing cortical thickness abnormalities in patients with bipolar disorder. Bipolar Disord. 2012;14(8):843–855.
   PubMed Web of Science ®Google Scholar
• Rimol LM, Hartberg CB, Nesvåg R, et al. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiatry. 2010;68(1):41–50.
   PubMed Web of Science ®Google Scholar
• Pol HEH, van Baal GCM, Schnack HG, et al. Overlapping and segregating structural brain abnormalities in twins with schizophrenia or bipolar disorder. Arch Gen Psychiatry. 2012;69(4):349–359.
   PubMedGoogle Scholar
• Maller JJ, Thaveenthiran P, Thomson RH, et al. Volumetric, cortical thickness and white matter integrity alterations in bipolar disorder type I and II. J Affect Disord. 2014;169:118–127.
   PubMed Web of Science ®Google Scholar
• Lyoo IK, Sung YH, Dager SR, et al. Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord. 2006;8(1):65–74.
   PubMed Web of Science ®Google Scholar
• Lan MJ, Chhetry BT, Oquendo MA, et al. Cortical thickness differences between bipolar depression and major depressive disorder. Bipolar Disord. 2014;16(4):378–388.
   PubMed Web of Science ®Google Scholar
• Hatton SN, Lagopoulos J, Hermens DF, et al. Cortical thinning in young psychosis and bipolar patients correlate with common neurocognitive deficits. Int J Bipolar Disord. 2013;1(1):3.
   PubMedGoogle Scholar
• Goghari VM, Macdonald AW 3rd, Sponheim SR. Temporal lobe structures and facial emotion recognition in schizophrenia patients and nonpsychotic relatives. Schizophr Bull. 2011 Nov;37(6):1281–1294. PubMed PMID: 20484523; PubMed Central PMCID: PMCPMC3196942. eng.
   PubMed Web of Science ®Google Scholar
• Wheeler AL, Wessa M, Szeszko PR, et al. Further neuroimaging evidence for the deficit subtype of schizophrenia: a cortical connectomics analysis. JAMA psychiatry. 2015;72(5):446–455.
   PubMed Web of Science ®Google Scholar
• Vederine F-E, Wessa M, Leboyer M, et al. A meta-analysis of whole-brain diffusion tensor imaging studies in bipolar disorder. Prog Neuro Psychopharmacol Biol Psychiatry. 2011;35(8):1820–1826.
   PubMed Web of Science ®Google Scholar
• Heng S, Song AW, Sim K. White matter abnormalities in bipolar disorder: insights from diffusion tensor imaging studies. J Neural Transm. 2010;117(5):639–654.
   PubMed Web of Science ®Google Scholar
• Benedetti F, Absinta M, Rocca MA, et al. Tract‐specific white matter structural disruption in patients with bipolar disorder. Bipolar Disord. 2011;13(4):414–424.
   PubMed Web of Science ®Google Scholar
• Duarte JA, de Araujo ESJQ, Goldani AA, et al. Neurobiological underpinnings of bipolar disorder focusing on findings of diffusion tensor imaging: a systematic review. Rev Bras psiquiatr (Sao Paulo, Brazil: 1999). 2016 Mar 22;38(2):167–175. PubMed PMID: 27007148; eng.
   PubMed Web of Science ®Google Scholar
• Gulseren S, Gurcan M, Gulseren L, et al. T2 hyperintensities in bipolar patients and their healthy siblings. Arch Med Res. 2006;37(1):79–85.
   PubMed Web of Science ®Google Scholar
• Adler CM, Adams J, DelBello MP, et al. Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: a diffusion tensor imaging study. Am J Psychiatry. 2006 Feb;163(2):322–324. PubMed PMID: 16449490.
   PubMed Web of Science ®Google Scholar
• Adler CM, Holland SK, Schmithorst V, et al. Abnormal frontal white matter tracts in bipolar disorder: a diffusion tensor imaging study. Bipolar Disord. 2004 Jun;6(3):197–203. PubMed PMID: 15117398; eng.
   PubMed Web of Science ®Google Scholar
• Frazier JA, Breeze JL, Papadimitriou G, et al. White matter abnormalities in children with and at risk for bipolar disorder. Bipolar Disord. 2007 Dec;9(8):799–809. PubMed PMID: 18076529; eng.
   PubMed Web of Science ®Google Scholar
• Beyer JL, Taylor WD, MacFall JR, et al. Cortical white matter microstructural abnormalities in bipolar disorder [Article]. Neuropsychopharmacology. 2005;30(12):2225–2229.
   PubMed Web of Science ®Google Scholar
• Liu JX, Chen YS, Hsieh JC, et al. Differences in white matter abnormalities between bipolar I and II disorders. J Affect Disord. 2010 Dec;127(1–3):309–315. PubMed PMID: 20598752.
   PubMed Web of Science ®Google Scholar
• Mahon K, Wu J, Malhotra AK, et al. A voxel-based diffusion tensor imaging study of white matter in bipolar disorder. Neuropsychopharmacology. 2009 May;34(6):1590–1600. PubMed PMID: 19145224; PubMed Central PMCID: PMC2811531.
   PubMed Web of Science ®Google Scholar
• Sprooten E, Fleming KM, Thomson PA, et al. White matter integrity as an intermediate phenotype: exploratory genome-wide association analysis in individuals at high risk of bipolar disorder. Psychiatry Res. 2013;206(2):223–231.
   PubMed Web of Science ®Google Scholar
• Li J, Edmiston EK, Chen K, et al. A comparative diffusion tensor imaging study of corpus callosum subregion integrity in bipolar disorder and schizophrenia. Psychiatry Res Neuroim. 2014;221(1):58–62.
   PubMed Web of Science ®Google Scholar
• O’Donoghue S, Holleran L, Cannon DM, et al. Anatomical dysconnectivity in bipolar disorder compared with schizophrenia: a selective review of structural network analyses using diffusion MRI. J Affect Disord. 2017;209:217–228.
   PubMed Web of Science ®Google Scholar
• Nenadić I, Hoof A, Dietzek M, et al. Diffusion tensor imaging of cingulum bundle and corpus callosum in schizophrenia vs. bipolar disorder. Psychiatry Res Neuroim. 2017;266:96–100.
   Web of Science ®Google Scholar
• Repple J, Meinert S, Grotegerd D, et al. A voxel‐based diffusion tensor imaging study in unipolar and bipolar depression. Bipolar Disord. 2017;19(1):23–31.
   PubMed Web of Science ®Google Scholar
• Mahon K, Burdick KE, Szeszko PR. A role for white matter abnormalities in the pathophysiology of bipolar disorder. Neurosci Biobehav Rev. 2010;34(4):533–554.
   PubMed Web of Science ®Google Scholar
• Canales-Rodríguez EJ, Pomarol-Clotet E, Radua J, et al. Structural abnormalities in bipolar euthymia: a multicontrast molecular diffusion imaging study. Biol Psychiatry. 2013;76(3):239–248.
   PubMed Web of Science ®Google Scholar
• Strakowski SM, Adler CM, Almeida J, et al. The functional neuroanatomy of bipolar disorder: a consensus model. Bipolar Disord. 2012;14(4):313–325.
   PubMed Web of Science ®Google Scholar
• Strakowski SM, Adler CM, Holland SK, et al. A preliminary FMRI study of sustained attention in euthymic, unmedicated bipolar disorder. Neuropsychopharmacology. 2004;29(9):1734–1740.
   PubMed Web of Science ®Google Scholar
• Chen CH, Suckling J, Lennox BR, et al. A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disord. 2011 Feb;13(1):1–15. PubMed PMID: 21320248; eng.
   PubMed Web of Science ®Google Scholar
• Phillips ML, Ladouceur CD, Drevets WC. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry. 2008;13(9):833–857.
   Web of Science ®Google Scholar
• Phillips ML, Drevets WC, Rauch SL, et al. Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol Psychiatry. 2003;54(5):515–528.
   PubMed Web of Science ®Google Scholar
• Houenou J, Frommberger J, Carde S, et al. Neuroimaging-based markers of bipolar disorder: evidence from two meta-analyses. J Affect Disord. 2011 Aug;132(3):344–355. PubMed PMID: 21470688; eng.
   PubMed Web of Science ®Google Scholar
• Townsend J, Altshuler LL. Emotion processing and regulation in bipolar disorder: a review. Bipolar Disord. 2012;14(4):326–339.
   PubMed Web of Science ®Google Scholar
• Liu J, Blond BN, van Dyck LI, et al. Trait and state corticostriatal dysfunction in bipolar disorder during emotional face processing. Bipolar Disord. 2012;14(4):432–441.
   PubMed Web of Science ®Google Scholar
• Vargas C, Lopez-Jaramillo C, Vieta E. A systematic literature review of resting state network–functional MRI in bipolar disorder. J Affect Disord. 2013 Sep 25;150(3):727–735. PubMed PMID: 23830141; eng.
   PubMed Web of Science ®Google Scholar
• Radaelli D, Sferrazza Papa G, Vai B, et al. Fronto-limbic disconnection in bipolar disorder. Eur Psychiatry. 2015 Jan;30(1):82–88. PubMed PMID: 24853295; eng.
   PubMed Web of Science ®Google Scholar
• Meda SA, Gill A, Stevens MC, et al. Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biol Psychiatry. 2012;71(10):881–889.
   PubMed Web of Science ®Google Scholar
• Grotegerd D, Stuhrmann A, Kugel H, et al. Amygdala excitability to subliminally presented emotional faces distinguishes unipolar and bipolar depression: an fMRI and pattern classification study. Hum Brain Mapp. 2014;35(7):2995–3007.
   PubMed Web of Science ®Google Scholar
• Almeida JR, Versace A, Hassel S, et al. Elevated amygdala activity to sad facial expressions: a state marker of bipolar but not unipolar depression. Biol Psychiatry. 2010;67(5):414–421.
   PubMed Web of Science ®Google Scholar
• Fournier JC, Keener MT, Almeida J, et al. Amygdala and whole‐brain activity to emotional faces distinguishes major depressive disorder and bipolar disorder. Bipolar Disord. 2013;15(7):741–752.
   PubMed Web of Science ®Google Scholar
• de Almeida JRC, Versace A, Mechelli A, et al. Abnormal amygdala-prefrontal effective connectivity to happy faces differentiates bipolar from major depression. Biol Psychiatry. 2009;66(5):451–459.
   PubMed Web of Science ®Google Scholar
• Hafizi S, Guma E, Koppel A, et al. TSPO expression and brain structure in the psychosis spectrum. Brain Behav Immun. 2018 Jun 12. pii: S0889-1591(18)30225-3. doi: 10.1016/j.bbi.2018.06.009. [Epub ahead of print].
   Google Scholar
• Reus GZ, Fries GR, Stertz L, et al. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience. 2015 Aug 6;300:141–154. PubMed PMID: 25981208.
   PubMed Web of Science ®Google Scholar
• Stertz L, Magalhaes PV, Kapczinski F. Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Curr Opin Psychiatry. 2013 Jan;26(1):19–26. PubMed PMID: 23196997.
   PubMed Web of Science ®Google Scholar
• Haarman BCB, Riemersma-Van der Lek RF, de Groot JC, et al. Neuroinflammation in bipolar disorder–A [11C]-(R)-PK11195 positron emission tomography study. Brain Behav Immun. 2014;40:219–225.
   PubMed Web of Science ®Google Scholar
• Setiawan E, Wilson AA, Mizrahi R, et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA psychiatry. 2015;72(3):268–275.
   PubMed Web of Science ®Google Scholar
• Hannestad J, DellaGioia N, Gallezot J-D, et al. The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [11C] PBR28 PET study. Brain Behav Immun. 2013;33:131–138.
   PubMed Web of Science ®Google Scholar
• Bloomfield PS, Selvaraj S, Veronese M, et al. Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [11C] PBR28 PET brain imaging study. Am J Psychiatry. 2015;173(1):44–52.
   PubMed Web of Science ®Google Scholar
• Gigante AD, Bond DJ, Lafer B, et al. Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord. 2012 Aug;14(5):478–487. PubMed PMID: 22834460; eng.
   PubMed Web of Science ®Google Scholar
• Brooks JO, Vizueta N. Diagnostic and clinical implications of functional neuroimaging in bipolar disorder. J Psychiatr Res. 2014;57:12–25.
   PubMed Web of Science ®Google Scholar
• Ongur D, Jensen JE, Prescot AP, et al. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry. 2008 Oct 15;64(8):718–726. PubMed PMID: 18602089; PubMed Central PMCID: PMCPMC2577764. eng.
   PubMed Web of Science ®Google Scholar
• Yuksel C, Ongur D. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry. 2010 Nov 1;68(9):785–794. PubMed PMID: 20728076; PubMed Central PMCID: PMCPMC2955841.
   PubMed Web of Science ®Google Scholar
• Frye MA, Watzl J, Banakar S, et al. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology. 2007 Dec;32(12):2490–2499. PubMed PMID: 17429412; eng.
   PubMed Web of Science ®Google Scholar
• Maddock RJ, Buonocore MH. MR spectroscopic studies of the brain in psychiatric disorders. Curr Top Behav Neurosci. 2012;11:199–251. PubMed PMID: 22294088; eng.
   PubMedGoogle Scholar
• Gallelli KA, Wagner CM, Karchemskiy A, et al. N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder. Bipolar Disord. 2005 Dec;7(6):589–597. PubMed PMID: 16403184; eng.
   PubMed Web of Science ®Google Scholar
• Hajek T, Bernier D, Slaney C, et al. A comparison of affected and unaffected relatives of patients with bipolar disorder using proton magnetic resonance spectroscopy. J Psychiatry Neurosci. 2008 Nov;33(6):531–540. PubMed PMID: 18982176; eng.
   PubMed Web of Science ®Google Scholar
• Moore GJ, Bebchuk JM, Hasanat K, et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects? Biol Psychiatry. 2000 Jul 1;48(1):1–8. PubMed PMID: 10913502; eng.
   PubMed Web of Science ®Google Scholar
• Kraguljac NV, Reid M, White D, et al. Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis. Psychiatry Res. 2012 Aug-Sep;203(2–3):111–125. PubMed PMID: 22981426; PubMed Central PMCID: PMCPMC3466386. eng.
   PubMed Web of Science ®Google Scholar
• Kalaycı D, Özdel O, Sözeri-Varma G, et al. A proton magnetic resonance spectroscopy study in schizoaffective disorder: comparison of bipolar disorder and schizophrenia. Prog Neuro Psychopharmacol Biol Psychiatry. 2012;37(1):176–181.
   PubMed Web of Science ®Google Scholar
• Spencer AE, Uchida M, Kenworthy T, et al. Glutamatergic dysregulation in pediatric psychiatric disorders: a systematic review of the magnetic resonance spectroscopy literature. J Clin Psychiatry. 2014;75(11):1226–1241.
   PubMed Web of Science ®Google Scholar
• Lawrie SM, Olabi B, Hall J, et al. Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia? World Psychiatry. 2011;10(1):19–31.
   PubMed Web of Science ®Google Scholar
• Kam JW, Bolbecker AR, O’Donnell BF, et al. Resting state EEG power and coherence abnormalities in bipolar disorder and schizophrenia. J Psychiatr Res. 2013 Dec;47(12):1893–1901. PubMed PMID: 24090715; PubMed Central PMCID: PMCPMC4015517.
   PubMed Web of Science ®Google Scholar
• El-Badri SM, Ashton CH, Moore PB, et al. Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder. Bipolar Disord. 2001 Apr;3(2):79–87. PubMed PMID: 11333067.
   PubMed Web of Science ®Google Scholar
• Basar E, Guntekin B, Atagun I, et al. Brain’s alpha activity is highly reduced in euthymic bipolar disorder patients. Cogn Neurodyn. 2012 Feb;6(1):11–20. PubMed PMID: 23372616; PubMed Central PMCID: PMCPMC3253163.
   PubMed Web of Science ®Google Scholar
• Maggioni E, Bianchi AM, Altamura AC, et al. The putative role of neuronal network synchronization as a potential biomarker for bipolar disorder: a review of EEG studies. J Affect Disord. 2017 Apr 1;212:167–170. PubMed PMID: 28159382.
   PubMed Web of Science ®Google Scholar
• Sanchez-Morla EM, Garcia-Jimenez MA, Barabash A, et al. P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia. Acta Psychiatr Scand. 2008 Apr;117(4):313–318. PubMed PMID: 18241306.
   PubMed Web of Science ®Google Scholar
• Salisbury DF, Shenton ME, Sherwood AR, et al. First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe. Arch Gen Psychiatry. 1998 Feb;55(2):173–180. PubMed PMID: 9477932; PubMed Central PMCID: PMCPMC2730913.
   PubMedGoogle Scholar
• Morsel AM, Morrens M, Dhar M, et al. Systematic review of cognitive event related potentials in euthymic bipolar disorder. Clin Neurophysiol. 2018 Sep;129(9):1854–1865. PubMed PMID: 29981961.
   PubMed Web of Science ®Google Scholar
• Chen SS, Tu PC, Su TP, et al. Impaired frontal synchronization of spontaneous magnetoencephalographic activity in patients with bipolar disorder. Neurosci Lett. 2008 Nov 14;445(2):174–178. PubMed PMID: 18786606.
   PubMed Web of Science ®Google Scholar
• Lee PS, Chen YS, Hsieh JC, et al. Distinct neuronal oscillatory responses between patients with bipolar and unipolar disorders: a magnetoencephalographic study. J Affect Disord. 2010 Jun;123(1–3):270–275. PubMed PMID: 19755202.
   PubMed Web of Science ®Google Scholar
• Alda M. Personalized psychiatry: many questions, fewer answers. J Psychiatry Neurosci. 2013 Nov;38(6):363–365. PubMed PMID: 24148844; PubMed Central PMCID: PMCPMC3819149.
   PubMed Web of Science ®Google Scholar
• Reinbold CS, Forstner AJ, Hecker J, et al. Analysis of the Influence of microRNAs in lithium response in bipolar disorder. Front Psychiatry. 2018;9:207. PubMed PMID: 29904359; PubMed Central PMCID: PMCPMC5991073.
   PubMed Web of Science ®Google Scholar
• Ritter PS, Bermpohl F, Gruber O, et al. Aims and structure of the German Research Consortium bipolife for the study of bipolar disorder. Int J Bipolar Disord. 2016 Dec;4(1):26. PubMed PMID: 27873290; PubMed Central PMCID: PMCPMC5118379.
   PubMedGoogle Scholar
• Budde M, Anderson-Schmidt H, Gade K, et al. A longitudinal approach to biological psychiatric research: the PsyCourse study. Am J Med Genet B Neuropsychiatr Genet. 2018 Aug 2. PubMed PMID: 30070057. DOI:10.1002/ajmg.b.32639
   PubMedGoogle Scholar
• Mentis AA, Pantelidi K, Dardiotis E, et al. Precision medicine and global health: the good, the bad, and the ugly. Front Med (Lausanne). 2018;5:67. PubMed PMID: 29594124; PubMed Central PMCID: PMCPMC5861134.
   PubMed Web of Science ®Google Scholar
• Madrid A, Papale LA, Alisch RS. New hope: the emerging role of 5-hydroxymethylcytosine in mental health and disease. Epigenomics. 2016 Jul;8(7):981–991. PubMed PMID: 27411884.
   PubMed Web of Science ®Google Scholar
• Xiao CL, Zhu S, He M, et al. N(6)-Methyladenine DNA modification in the human genome. Mol Cell. 2018 Jul 19;71(2):306–318 e7. PubMed PMID: 30017583.
   PubMed Web of Science ®Google Scholar
• Fries GR, Quevedo J. Exosomal microRNAs as potential biomarkers in neuropsychiatric disorders. Methods Mol Biol. 2018;1733:79–85. PubMed PMID: 29435924.
   PubMedGoogle Scholar